ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

EXAS EXACT Sciences Corporation

50.48
-1.47 (-2.83%)
May 17 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 2,453,347
Bid Price 50.45
Ask Price 51.10
News -
Day High 52.05

Low
50.35

52 Week Range

High
100.77

Day Low 50.35
Company Name Stock Ticker Symbol Market Type
EXACT Sciences Corporation EXAS NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-1.47 -2.83% 50.48 19:47:52
Open Price Low Price High Price Close Price Prev Close
52.05 50.35 52.05 50.38 51.95
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
30,953 2,453,347 $ 51.08 $ 125,315,181 - 50.35 - 100.77
Last Trade Time Type Quantity Stock Price Currency
19:47:52 6 $ 50.60 USD

EXACT Sciences (EXAS) Options Flow Summary

Overall Flow

Bearish

Net Premium

-48k

Calls / Puts

50.00%

Buys / Sells

100.00%

OTM / ITM

100.00%

Sweeps Ratio

0.00%

EXACT Sciences Corporation Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
9.14B 181.53M - 2.58B -204.15M -1.12 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

EXACT Sciences News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No EXAS Message Board. Create One! See More Posts on EXAS Message Board See More Message Board Posts

Historical EXAS Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week54.4156.7950.3553.683,538,305-3.93-7.22%
1 Month62.8465.0050.3557.362,918,269-12.36-19.67%
3 Months59.7579.6250.3562.682,766,774-9.27-15.51%
6 Months61.9079.6250.3564.082,259,041-11.42-18.45%
1 Year80.32100.7750.3570.671,894,111-29.84-37.15%
3 Years95.81133.9929.2767.361,962,794-45.33-47.31%
5 Years96.83159.5429.2780.101,919,646-46.35-47.87%

EXACT Sciences Description

Exact Sciences Corporation, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test, a non-invasive stool-based DNA test, is a pre-cancer screening test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a genetic-based treatment selection test for breast, prostate, and colon cancers. With the acquisitions of Base Genomics and Thrive Earlier Detection, Exact is building a multi-cancer early screening test to detect over 14 cancers, a test that would be one of earliest entrants in multi-cancer liquid biopsy cancer screening.